This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Must-See Chart: WellPoint Is a Healthy Buy

NEW YORK ( TheStreet) -- If a picture paints a thousand words, the WellPoint (WLP) chart speaks volumes about this undervalued health benefits company.

It won't take a thousand words to help us see why the following one-year chart clearly signals that WLP has momentum and upside potential.


WLP Chart WLP data by YCharts

Supported by its rising quarterly revenue per share (the orange line), WellPoint shares have skyrocketed more than 56% in less than 12 months before its latest cool-down to just above $86 per share. What's been the rocket fuel that has lifted the stock of this health insurance company to a market cap of over $25.4 billion?

WellPoint is in the right business at the right time.

It provides network-based managed-care plans to large and small employers, individuals, Medicaid and senior markets in the United States. It also provides various managed care services including claims processing, underwriting, stop loss insurance and other administrative services to self-funded customers.

But the big payday for WellPoint and other health insurance administrators is the Affordable Care Act, and its provisions for expanded state Medicaid coverage through managed care plans. This is an enormous growth opportunity for companies that specialize in managing these low-income population groups.

According to a recent article by Bruce Jaspen, the feds will be dolling out big bucks starting this year:

"As state budgets have been hurt by the stagnant economy, lawmakers have turned more patients eligible for Medicaid over to privately contracted insurance companies. Now, the health law provides a cash infusion of more than $900 billion in federal dollars from 2014 to 2022 to expand Medicaid programs for states interested in the proposition."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
WLP $136.01 1.43%
AAPL $132.76 1.00%
FB $80.81 0.41%
GOOG $541.15 -0.25%
TSLA $247.84 0.90%

Markets

DOW 18,270.92 -14.82 -0.08%
S&P 500 2,130.71 -0.11 -0.01%
NASDAQ 5,099.8820 +9.0880 0.18%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs